BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8548770)

  • 1. Overexpression of cyclin D1 enhances gene amplification.
    Zhou P; Jiang W; Weghorst CM; Weinstein IB
    Cancer Res; 1996 Jan; 56(1):36-9. PubMed ID: 8548770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells.
    Asano K; Sakamoto H; Sasaki H; Ochiya T; Yoshida T; Ohishi Y; Machida T; Kakizoe T; Sugimura T; Terada M
    Biochem Biophys Res Commun; 1995 Dec; 217(3):1169-76. PubMed ID: 8554573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
    Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic instability and apoptosis are frequent in p53 deficient young mice.
    Fukasawa K; Wiener F; Vande Woude GF; Mai S
    Oncogene; 1997 Sep; 15(11):1295-302. PubMed ID: 9315097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of cyclin D1 in epithelial ovarian cancers.
    Worsley SD; Ponder BA; Davies BR
    Gynecol Oncol; 1997 Feb; 64(2):189-95. PubMed ID: 9038263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
    Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB
    Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines.
    Mac SM; Farnham PJ
    Mol Carcinog; 2000 Feb; 27(2):84-96. PubMed ID: 10657901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth.
    Han EK; Sgambato A; Jiang W; Zhang YJ; Santella RM; Doki Y; Cacace AM; Schieren I; Weinstein IB
    Oncogene; 1995 Mar; 10(5):953-61. PubMed ID: 7898937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of a human cDNA encoding a trifunctional enzyme of carbamoyl-phosphate synthetase-aspartate transcarbamoylase-dihydroorotase in de Novo pyrimidine synthesis.
    Iwahana H; Fujimura M; Ii S; Kondo M; Moritani M; Takahashi Y; Yamaoka T; Yoshimoto K; Itakura M
    Biochem Biophys Res Commun; 1996 Feb; 219(1):249-55. PubMed ID: 8619816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional repression of human cad gene by hypoxia inducible factor-1alpha.
    Chen KF; Lai YY; Sun HS; Tsai SJ
    Nucleic Acids Res; 2005; 33(16):5190-8. PubMed ID: 16155188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
    Lebwohl DE; Muise-Helmericks R; Sepp-Lorenzino L; Serve S; Timaul M; Bol R; Borgen P; Rosen N
    Oncogene; 1994 Jul; 9(7):1925-9. PubMed ID: 8208539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
    Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter.
    Kollmar R; Sukow KA; Sponagle SK; Farnham PJ
    J Biol Chem; 1994 Jan; 269(3):2252-7. PubMed ID: 7905000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
    Geum D; Sun W; Paik SK; Lee CC; Kim K
    Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cyclin D1 overexpression by activated ras.
    Filmus J; Robles AI; Shi W; Wong MJ; Colombo LL; Conti CJ
    Oncogene; 1994 Dec; 9(12):3627-33. PubMed ID: 7970723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer.
    Naitoh H; Shibata J; Kawaguchi A; Kodama M; Hattori T
    Am J Pathol; 1995 May; 146(5):1161-9. PubMed ID: 7747810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
    Nikaido T; Li SF; Shiozawa T; Fujii S
    Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
    Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
    Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of cyclin D1 and other molecular markers to cancer chemoprevention.
    Weinstein IB
    J Cell Biochem Suppl; 1996; 25():23-8. PubMed ID: 9027594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene amplification].
    Taira M; Koike K
    Tanpakushitsu Kakusan Koso; 1984 Mar; 29(3):152-63. PubMed ID: 6425988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.